EUVIMEDEUVIMED entdecken
Open Access

Per- and Polyfluoroalkyl Substances During Pregnancy and Gestational Diabetes: The Environmental Influences on Child Health Outcomes (ECHO) Cohort

Anne P Starling iD, Mohamad Burjak, Adaeze W Nzegwu, Xiaoshuang Xun, John L Adgate, Emily S Barrett, Deborah H Bennett, Leda Chatzi, Elena Colicino, Dana Dabelea, Anne L Dunlop, Stephanie M Eick und 18 weitere

Diabetes Care · 01.05.2026 · 49 (5) · 852-860

DOI: 10.2337/dc25-1340 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Diabetes Care, online erschienen am 24.03.2026. Verfasst von Anne P Starling und 29 weiteren Autor:innen. Beteiligte Einrichtung: Department of Epidemiology, Gillings School of Global Public Health, University of North Carolina at Chapel Hill, Chapel Hill, NC. Hauptthemen laut MEDLINE: Diabetes, Gestational, Fluorocarbons. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIEHS NIH HHS, NIH Office of the Director, NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

OBJECTIVE Exposure to per- and polyfluoroalkyl substances (PFAS) may increase the risk of gestational diabetes mellitus (GDM), with adverse consequences for pregnant women and their offspring. However, epidemiologic studies have shown inconsistent results. We addressed this question in a large, pooled sample of U.S. women. RESEARCH DESIGN AND METHODS Participants (n = 5,229) from 16 cohorts had singleton pregnancies. PFAS were quantified in a single plasma or serum sample during pregnancy (1999–2021); six PFAS detected in ≥60% of participants were analyzed. The primary outcome was GDM diagnosis based on self-report or medical record documentation. The secondary outcome, among 1,213 participants, was fasting glucose. We estimated associations between each PFAS and GDM using generalized estimating equations models with Poisson distribution and robust variance, and estimated associations between each PFAS and fasting glucose using generalized estimating equations models for linear regression. Effect modification by prepregnancy BMI or race and ethnicity was evaluated via interaction terms and stratification. We quantified the combined effect of the PFAS mixture using quantile-based g-computation. RESULTS Associations between individual PFAS and GDM were null or weakly inverse; the association with the six-PFAS mixture was negative (prevalence ratio [95% CI] per quartile increase: 0.75 [0.58, 0.96]). Certain PFAS were more strongly negatively associated with GDM among participants with BMI <25 kg/m2. Associations between PFAS and fasting glucose were largely null, although both positive and negative associations were observed in specific race and ethnicity strata. CONCLUSIONS In a large, pooled sample of U.S. pregnant women, greater concentrations of PFAS were not associated with higher prevalence of GDM.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diabetes, GestationalFluorocarbonsHumansFemalePregnancyAdultCohort StudiesBlood Glucose

Substanzen

FluorocarbonsBlood Glucose

Autor:innen und Institutionen

  • Department of Epidemiology, Gillings School of Global Public Health, University of North Carolina at Chapel Hill, Chapel Hill, NC.
  • Lifecourse Epidemiology of Adiposity and Diabetes Center, University of Colorado Anschutz Medical Campus, Aurora, CO.
  • Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Johns Hopkins University, Baltimore, MD.
  • Department of Environmental and Occupational Health, Colorado School of Public Health, University of Colorado Anschutz Medical Campus, Aurora, CO.
  • Department of Biostatistics and Epidemiology, Environmental and Occupational Health Sciences Institute, Rutgers School of Public Health, Piscataway, NJ.
  • Department of Public Health Sciences, School of Medicine, University of California, Davis, Davis, CA.

ORCID-Profile: Anne P Starling, Damaskini Valvi

Förderung

  • NIEHS NIH HHS
  • NIH Office of the Director
  • NIH HHS
  • NHGRI NIH HHS
  • National Institute of Environmental Health Sciences
  • National Human Genome Research Institute

Zitieren

APA

Starling, A. P., Burjak, M., Nzegwu, A. W., Xun, X., Adgate, J. L., Barrett, E. S., Bennett, D. H., Chatzi, L., Colicino, E., Dabelea, D., Dunlop, A. L., Eick, S. M., Farzan, S. F., Ferrara, A., Fleisch, A. F., Geiger, S. D., Hedderson, M. M., Kahn, L. G., Karagas, M. R., …, & ECHO Cohort Consortium* (2026). Per- and Polyfluoroalkyl Substances During Pregnancy and Gestational Diabetes: The Environmental Influences on Child Health Outcomes (ECHO) Cohort. Diabetes Care, 49(5), 852-860. https://doi.org/10.2337/dc25-1340

Vancouver

Starling AP, Burjak M, Nzegwu AW, Xun X, Adgate JL, Barrett ES, et al. Per- and Polyfluoroalkyl Substances During Pregnancy and Gestational Diabetes: The Environmental Influences on Child Health Outcomes (ECHO) Cohort. Diabetes Care. 2026;49(5):852-860. doi:10.2337/dc25-1340

BibTeX
@article{Starling2026,
  author = {Starling, Anne P and Burjak, Mohamad and Nzegwu, Adaeze W and Xun, Xiaoshuang and Adgate, John L and Barrett, Emily S and Bennett, Deborah H and Chatzi, Leda and Colicino, Elena and Dabelea, Dana and Dunlop, Anne L and Eick, Stephanie M and Farzan, Shohreh F and Ferrara, Assiamira and Fleisch, Abby F and Geiger, Sarah D and Hedderson, Monique M and Kahn, Linda G and Karagas, Margaret R and Kelly, Rachel S and Liang, Donghai and Lin, Pi-I and O'Connor, Thomas G and Padula, Amy M and Peterson, Alicia K and Romano, Megan E and Sathyanarayana, Sheela and Zhu, Yeyi and Valvi, Damaskini and ECHO Cohort Consortium*, ECHO Cohort Consortium*},
  title = {Per- and Polyfluoroalkyl Substances During Pregnancy and Gestational Diabetes: The Environmental Influences on Child Health Outcomes (ECHO) Cohort},
  journal = {Diabetes Care},
  year = {2026},
  volume = {49},
  number = {5},
  pages = {852--860},
  doi = {10.2337/dc25-1340}
}
Kostenlos starten →